Theodore A. Boutacoff
Geen lopende functies
Loopbaan van Theodore A. Boutacoff
Eerdere bekende functies van Theodore A. Boutacoff
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| IRIDEX CORPORATION | Directeur/Bestuurslid | 13-07-2011 | 11-10-2011 |
| Hoofd Techniek/Wetenschap/O&O | 11-10-2011 | 01-02-2013 | |
| Oprichter | 01-02-1989 | 01-02-2013 | |
| President | 18-05-2010 | 11-10-2011 | |
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Directeur/Bestuurslid | - | - |
Opleiding van Theodore A. Boutacoff
| Stanford University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
Operationeel
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Consumer Services | 2 |
| Health Services | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| IRIDEX CORPORATION | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Health Services |